ClearView 3 IOL
PMA P200020
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP200020 | Date22 Jul 2022 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade Name
- SBL-3 Multifocal Intraocular Lens
- Generic Name
- Lens, multifocal intraocular
- PMA Number
- FDA Product Code
- MFK
- Device Class
- Class III
- Regulation
- 21 CFR Part 886.3600
- Advisory Committee
- Ophthalmic
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The SBL-3 Multifocal Intraocular Lens is a Lens, multifocal intraocular (Device Class III) designed for primary implantation to correct aphakia in adult patients. It provides a bifocal optical design to mitigate presbyopia, offering improved near visual acuity while maintaining comparable distance and intermediate vision compared to aspheric monofocal alternatives. The lens is specifically intended for capsular bag placement and is indicated for patients with 1 diopter or less of pre-existing corneal astigmatism following cataract removal.
This device is supplied sterile and intended for single-use. It is regulated under FDA PMA (Premarket Approval) with approval number P200020, and its use is restricted to ophthalmic surgical settings. The lens is available in multiple lot/serialized variants as indicated by the registration numbers (e.g., 3002807314, 1119421). Storage and handling must comply with sterile surgical protocols, and its design does not include MRI-compatible materials or features.
Other devices from Lenstec, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the ClearView 3 IOL, and who is it designed for?
The ClearView 3 IOL (SBL-3 Multifocal Intraocular Lens) is designed for primary implantation to correct aphakia in adult patients following cataract removal. It specifically targets patients with 1 diopter or less of pre-existing corneal astigmatism and aims to mitigate presbyopia by providing a bifocal optical design. This design improves near visual acuity while maintaining comparable distance and intermediate vision compared to aspheric monofocal alternatives.
Is the ClearView 3 IOL intended for reuse, or is it meant for single-use only?
The ClearView 3 IOL is explicitly supplied sterile and intended for single-use only. This aligns with standard sterile surgical protocols, ensuring patient safety and preventing cross-contamination in ophthalmic settings.
How should the ClearView 3 IOL be stored, and what considerations should be taken into account?
The ClearView 3 IOL must be stored and handled according to sterile surgical protocols due to its sterile packaging. Since it is not MRI-compatible, it should be stored in an environment where it won’t be exposed to MRI machines, as this could potentially damage or alter its properties. Always follow manufacturer guidelines for storage conditions to maintain sterility and functionality.
What are the key differences in visual outcomes when using the ClearView 3 IOL compared to an aspheric monofocal IOL?
The ClearView 3 IOL provides improved near visual acuity compared to aspheric monofocal IOLs while maintaining comparable distance and intermediate vision. Its bifocal design is intended to reduce the need for additional vision correction tools (like glasses or magnifying lenses) for near tasks, as evidenced by patient-reported outcomes.
How do I identify the specific lot or serialized variant of the ClearView 3 IOL I am using?
Each ClearView 3 IOL is available in multiple serialized variants, identifiable by registration numbers such as 3002807314, 1119421, or others listed in the product documentation. These numbers help track individual units for inventory and quality assurance purposes.